1. Home
  2. GOSS vs AREN Comparison

GOSS vs AREN Comparison

Compare GOSS & AREN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • AREN
  • Stock Information
  • Founded
  • GOSS 2015
  • AREN 2016
  • Country
  • GOSS United States
  • AREN United States
  • Employees
  • GOSS N/A
  • AREN N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • AREN Medical/Dental Instruments
  • Sector
  • GOSS Health Care
  • AREN Health Care
  • Exchange
  • GOSS Nasdaq
  • AREN Nasdaq
  • Market Cap
  • GOSS 347.8M
  • AREN 305.8M
  • IPO Year
  • GOSS 2019
  • AREN N/A
  • Fundamental
  • Price
  • GOSS $1.84
  • AREN $6.11
  • Analyst Decision
  • GOSS Strong Buy
  • AREN Strong Buy
  • Analyst Count
  • GOSS 4
  • AREN 1
  • Target Price
  • GOSS $8.25
  • AREN $10.00
  • AVG Volume (30 Days)
  • GOSS 3.6M
  • AREN 279.4K
  • Earning Date
  • GOSS 08-11-2025
  • AREN 08-18-2025
  • Dividend Yield
  • GOSS N/A
  • AREN N/A
  • EPS Growth
  • GOSS N/A
  • AREN N/A
  • EPS
  • GOSS N/A
  • AREN 0.16
  • Revenue
  • GOSS $124,590,000.00
  • AREN $128,781,000.00
  • Revenue This Year
  • GOSS N/A
  • AREN $275.98
  • Revenue Next Year
  • GOSS $65.50
  • AREN N/A
  • P/E Ratio
  • GOSS N/A
  • AREN $28.11
  • Revenue Growth
  • GOSS N/A
  • AREN N/A
  • 52 Week Low
  • GOSS $0.66
  • AREN $0.56
  • 52 Week High
  • GOSS $1.94
  • AREN $10.05
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 70.54
  • AREN 52.75
  • Support Level
  • GOSS $1.67
  • AREN $5.15
  • Resistance Level
  • GOSS $1.94
  • AREN $6.57
  • Average True Range (ATR)
  • GOSS 0.14
  • AREN 0.52
  • MACD
  • GOSS 0.04
  • AREN 0.02
  • Stochastic Oscillator
  • GOSS 86.81
  • AREN 58.38

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

Share on Social Networks: